ORLANDO, Fla., March 8 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. (the “Company” or “Telzuit”) announced today that the NASDAQ has changed the Company’s stock trading symbol back to “TZMT” from “TZMTE,” effective today, following the filing of the Company’s Quarterly Report on Form 10-QSB for the quarter ended December 31, 2005.
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The first step in this mission will initially take the form of our state-of-the-art, FDA approved, Bio-Patch Wireless Heart Monitor. This is a full 12-lead, completely wireless, Holter monitor, which is new to the marketplace. Telzuit is also building its own dedicated intranet as a platform to handle several of the products it will be releasing, including its initial product, the Bio-Patch Wireless Heart Monitor. More information on Telzuit, its business model, and its products can be found on its Web site: http://www.telzuit.com , or by calling 407-354-1222.
Forward-Looking Statement
Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
Contacts: Telzuit Medical Technologies, Inc., Orlando James Tolan, Senior VP +1-407-354-1222 Brainerd Communicators, Inc. Jennifer Gery (Media) Todd St. Onge (Investors) +1-212-986-6667
Telzuit Medical Technologies, Inc.
CONTACT: James Tolan, Senior VP, Telzuit Medical Technologies, Inc.,+1-407-354-1222; or Media, Jennifer Gery, or Investors, Todd St. Onge,+1-212-986-6667, both of Brainerd Communicators, Inc., for Telzuit MedicalTechnologies, Inc.
Web site: http://www.telzuit.com/